Does Cap Assisted Colonoscopy Improve Detection of Adenomatous Polyps? (CAP Trial)
CAP
1 other identifier
interventional
1,148
1 country
2
Brief Summary
Effectiveness of screening colonoscopy in cancer prevention relies on the detection and removal of adenomatous polyps. However, a substantial rate of adenomas is missed during a colonoscopy. It has been estimated that two thirds of missed adenomas are located on the proximal aspect of colonic folds. Attaching a transparent cap to the tip of a colonoscope may allow examination of the proximal aspect of colonic folds, and some early studies have suggested an increased polyp and adenoma detection using this technology. However, the studies have in part substantial methodological limitations (e.g. missing polyp histology, single endoscopist study, polyps not removed at the time of detection). Therefore, at this point it is unclear whether cap assisted colonoscopy may improve adenoma detection. The objective of this study is to evaluate whether cap assisted colonoscopy improves adenoma detection. The investigators propose a two-center multiple endoscopists randomized controlled trial. Patients will be randomized to cap assisted colonoscopy or standard high definition white light colonoscopy. The cap is a 4mm commercially available transparent cap that is attached to the tip of the colonoscopy. Primary outcome measure is the adenoma detection rate (mean number of adenoma per patient). The investigators will assess and adjust for possible variables that can affect adenoma detection, including withdrawal time and quality of colon preparation. As a secondary outcome of interest the investigators will evaluate a possible learning curve effect among all endoscopists (a minimum of six) new to this method. In addition the investigators will evaluate whether cap assisted endoscopy improves real time prediction of polyp histology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2010
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 19, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedFirst Posted
Study publicly available on registry
September 4, 2013
CompletedResults Posted
Study results publicly available
May 30, 2017
CompletedSeptember 25, 2018
August 1, 2018
1.4 years
January 19, 2012
March 4, 2017
August 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Number of Adenomas
Mean number of adenomas per patient in each group.
duration of colonoscopy
Secondary Outcomes (6)
Adenoma Detection Rate
duration of colonoscopy
Advanced Adenoma Detection Rate
duration of colonoscopy
Quality of Bowel Preparation
duration of colonoscopy
Withdrawal Time
time of colonoscope withdrawal
Ease of Terminal Ileum Intubation
during colonoscopy
- +1 more secondary outcomes
Study Arms (2)
Standard colonoscopy
NO INTERVENTIONCap assisted colonoscopy
ACTIVE COMPARATORA transparent cap will be affixed to tip of the high-definition wide angle colonoscope.
Interventions
4mm transparent cap (Olympus) mounted to the tip of a colonoscope.
Eligibility Criteria
You may not qualify if:
- Patients with known inflammatory bowel disease or active colitis
- Patients with familial adenomatous polyposis or other genetic syndromes that are associated with a high number of colonic polyps
- Patients who are receiving an emergency colonoscopy
- Poor general health (ASA class \> 3)
- Patients on coumadin at the time of the procedure or with a coagulopathy and an elevated INR ≥ 1.5, or platelets \< 50
- Patients who do not consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
White River Junction VAMC
White River Junction, Vermont, 05009, United States
Related Publications (3)
von Renteln D, Kaltenbach T, Rastogi A, Anderson JC, Rosch T, Soetikno R, Pohl H. Simplifying Resect and Discard Strategies for Real-Time Assessment of Diminutive Colorectal Polyps. Clin Gastroenterol Hepatol. 2018 May;16(5):706-714. doi: 10.1016/j.cgh.2017.11.036. Epub 2017 Nov 23.
PMID: 29174789DERIVEDvon Renteln D, Robertson DJ, Bensen S, Pohl H. Prolonged cecal insertion time is associated with decreased adenoma detection. Gastrointest Endosc. 2017 Mar;85(3):574-580. doi: 10.1016/j.gie.2016.08.021. Epub 2016 Aug 31.
PMID: 27590962DERIVEDPohl H, Bensen SP, Toor A, Gordon SR, Levy LC, Berk B, Anderson PB, Anderson JC, Rothstein RI, MacKenzie TA, Robertson DJ. Cap-assisted colonoscopy and detection of Adenomatous Polyps (CAP) study: a randomized trial. Endoscopy. 2015 Oct;47(10):891-7. doi: 10.1055/s-0034-1392261. Epub 2015 Jun 30.
PMID: 26126162DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Heiko Pohl
- Organization
- VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Heiko Pohl
White River Junction VAMC, Dartmouth Medical School
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PI
Study Record Dates
First Submitted
January 19, 2012
First Posted
September 4, 2013
Study Start
December 1, 2010
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
September 25, 2018
Results First Posted
May 30, 2017
Record last verified: 2018-08